Technology News and Research

RSS

Five physicians named recipients of 2014 Hastings Center Cunniff-Dixon Physician Awards

Five physicians who have distinguished themselves in advancing the practice of palliative care and modeling exemplary skill and compassion at the bedside have been named recipients of the 2014 Hastings Center Cunniff-Dixon Physician Awards.

22 Jan 2014

CIPROMS signs renewal agreement for Zix Email Encryption

Zix Corporation, a leader in email data protection, announces that CIPROMS has signed a three-year renewal for Zix Email Encryption. Providing revenue cycle management to 80 private medical practices throughout Indiana, CIPROMS uses Zix Email Encryption to secure protected health information in email, meet requirements under Health Insurance Portability and Accountability Act and protect client relationships with covered entities that must also comply with healthcare industry privacy and data security regulations.

22 Jan 2014

EKF Diagnostics announces major breakthrough for PointMan DNA enrichment technology

EKF, announces a major breakthrough for its PointMan DNA enrichment technology for potential use in future cancer testing and treatment.

From EKF Diagnostics 22 Jan 2014

Clues of "silent thief of sight”: Glaucoma

Glaucoma is sometimes called the "silent thief of sight" because it slowly damages the eyes and can cause irreparable harm before there is any vision loss. But this disease is stealthy in more ways than one.

22 Jan 2014

Italian biochemist receives Louis-Jeantet Prize for Medicine for the year 2014

The 2014 LOUIS-JEANTET PRIZE FOR MEDICINE is awarded to the Italian biochemist Elena Conti, Director of the Department of Structural Cell Biology at the Max-Planck Institute of Biochemistry in Munich (Germany) and to Denis Le Bihan, the French medical doctor, physicist and Director of NeuroSpin, an institute at the French Nuclear and Renewable Energy Commission (CEA) at Saclay near Paris.

22 Jan 2014

Older brains slow not due to cognitive decline, but increased experience

What happens to our cognitive abilities as we age? Traditionally it is thought that age leads to a steady deterioration of brain function, but new research in Topics in Cognitive Science argues that older brains may take longer to process ever increasing amounts of knowledge, and this has often been misidentified as declining capacity.

22 Jan 2014

Viewpoints: High Court's scrutiny of home health workers law; patient 'dumping' on LA's skid row; hospital fund raising

On Tuesday the Supreme Court will hear arguments in Harris v. Quinn, ... It was brought by the National Right to Work Legal Defense Foundation (NRTW), whose mission is to use "strategic litigation" to "eliminate coercive union power and compulsory unionism abuses," in this case on behalf of several personal assistants who provide in-home services to persons with disabilities under Illinois's Medicaid program.

22 Jan 2014

Scientists showcase HDL nanotherapy that may provide solution to repeat heart attacks

Up to 30 percent of heart attack patients suffer a new heart attack because cardiologists are unable to control inflammation inside heart arteries - the process that leads to clots rupturing and causing myocardial infarction or stroke.

22 Jan 2014

Trials, and a few unexpected triumphs, for insurance exchanges

A procurement document posted on a federal website gives the newest Obamacare contractor until mid-March to build the back end of healthcare.gov, predicting dire consequences if the work is not completed on time. Other media outlets report exchange developments from Maryland, Massachusetts, Missouri, North Carolina, Oregon, Wisconsin, Georgia and Minnesota.

22 Jan 2014

Magnetoencephalography can be used to control and train specific targeted brain regions

A new brain-imaging technique enables people to 'watch' their own brain activity in real time and to control or adjust function in pre-determined brain regions. The study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, published in NeuroImage, is the first to demonstrate that magnetoencephalography can be used as a potential therapeutic tool to control and train specific targeted brain regions.

21 Jan 2014

Damon Runyon Cancer Research Foundation awards $2.25M to six innovative young scientists

The Damon Runyon Cancer Research Foundation announced that six scientists with novel approaches to fighting cancer have been named 2014 recipients of the Damon Runyon-Rachleff Innovation Award. The grant of $450,000 over three years is awarded each year to early career scientists whose projects have the potential to significantly impact the prevention, diagnosis and treatment of cancer.

21 Jan 2014

University of Liverpool awarded £3.2 million to develop new diagnostic tests for cancers

The University of Liverpool has been awarded -3.2 million to develop new diagnostic tests for cervical, oesophageal and prostate cancer patients.

21 Jan 2014

Vivaldi Biosciences inks agreement with NIAID to evaluate LAIV candidates against influenza A

Vivaldi Biosciences Inc., a clinical-stage biotechnology company developing live attenuated influenza vaccines against seasonal and pandemic influenza, today announced that it has signed a Cooperative Research and Development Agreement with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to generate and evaluate in preclinical studies LAIV candidates against influenza A(H7N9).

21 Jan 2014

Fluxion Biosciences announces release of IsoFlux Rare Cell Enrichment Kit

Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.

From Fluxion Biosciences 21 Jan 2014

HUB Foundation for Organoid Technology signs licensing agreement with STEMCELL Technologies

The HUB Foundation for Organoid Technology announced today that it has signed a licensing agreement with STEMCELL Technologies Inc. for the manufacturing and worldwide distribution of cell culture media for growing Organoids. Organoids are mini-organs grown in tissue culture from small pieces of tissue derived from patients with cancer and other diseases, and represent an exciting new tool for scientific research and drug discovery and validation.

21 Jan 2014

HealthTrust selects BC Technical as provider for refurbished medical imaging equipment

BC Technical, a leading non-OEM medical imaging solutions provider, announced today that it has been selected by HealthTrust as a provider for refurbished medical imaging equipment for the 1,400 acute care facilities that are part of the HealthTrust membership.

21 Jan 2014

Dakim introduces new tool to monitor cognitive performance of residents in senior living communities

Dakim, Inc., the leader in cognitive therapy in the senior living market, has introduced BrainTrac, a new tool that monitors the cognitive performance of residents in senior living communities who use the Dakim BrainFitness system.

21 Jan 2014

Oxford Finance closes $31.6M debt financing expansion with Proteus Digital Health

Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a $31.6 million debt financing expansion with Proteus Digital Health. The financing package, which was provided to Proteus Digital Health from both Oxford and Silicon Valley Bank, included a senior secured term loan and a revolving line of credit. Proceeds of the loan will be used for working capital growth.

21 Jan 2014

Trendlines Labs signs deal for collaboration with Roper St. Francis Healthcare

Trendlines Labs (a unit of the Trendlines Group) recently signed an agreement for collaboration with Roper St. Francis Healthcare.

21 Jan 2014

First patient dosed in ADXS-HPV Phase 1/2 study for HPV-associated head and neck cancer

Advaxis, Inc., a leader in developing the next generation of cancer immunotherapies, announced that the first patient has been dosed in a Phase 1/2 "window of opportunity" study being conducted by the Icahn School of Medicine at Mount Sinai. Patients diagnosed with HPV-associated head and neck cancer will receive ADXS-HPV immunotherapy during the "window" of time between initial diagnosis and minimally invasive transoral robotic surgery to remove their tumors.

21 Jan 2014

Technology News and Research

Five physicians named recipients of 2014 Hastings Center Cunniff-Dixon Physician Awards

CIPROMS signs renewal agreement for Zix Email Encryption

EKF Diagnostics announces major breakthrough for PointMan DNA enrichment technology

Clues of "silent thief of sight”: Glaucoma

Italian biochemist receives Louis-Jeantet Prize for Medicine for the year 2014

Older brains slow not due to cognitive decline, but increased experience

Viewpoints: High Court's scrutiny of home health workers law; patient 'dumping' on LA's skid row; hospital fund raising

Scientists showcase HDL nanotherapy that may provide solution to repeat heart attacks

Trials, and a few unexpected triumphs, for insurance exchanges

Magnetoencephalography can be used to control and train specific targeted brain regions

Damon Runyon Cancer Research Foundation awards $2.25M to six innovative young scientists

University of Liverpool awarded £3.2 million to develop new diagnostic tests for cancers

Vivaldi Biosciences inks agreement with NIAID to evaluate LAIV candidates against influenza A

Fluxion Biosciences announces release of IsoFlux Rare Cell Enrichment Kit

HUB Foundation for Organoid Technology signs licensing agreement with STEMCELL Technologies

HealthTrust selects BC Technical as provider for refurbished medical imaging equipment

Dakim introduces new tool to monitor cognitive performance of residents in senior living communities

Oxford Finance closes $31.6M debt financing expansion with Proteus Digital Health

Trendlines Labs signs deal for collaboration with Roper St. Francis Healthcare

First patient dosed in ADXS-HPV Phase 1/2 study for HPV-associated head and neck cancer

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News